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Objective: Previous studies have investigated the predictive value of clinical and morphologic parameters for distal
embolization during carotid interventions. The composition of the atherosclerotic plaque, using virtual histology
intravascular ultrasound (VH-IVUS) imaging obtained with an IVUS catheter that is advanced through the lesion after
a filter has been placed distally, has not been evaluated as a marker for cerebral embolization. The purpose of this study
was to assess the relationship between atherosclerotic plaque composition determined with VH-IVUS and the occurrence
of cerebral embolization after carotid artery stenting (CAS).
Methods: During a 10-month period, 24 patients undergoing CAS procedures using a filter device for embolic protection
were prospectively evaluated. All patients underwent VH-IVUS exams at the time of the intervention, transcranial
Doppler (TCD) monitoring during CAS, and pre- and 24-hour postprocedural diffusion-weighted magnetic resonance
imaging (DW-MRI) exams. Using VH-IVUS, plaque components were characterized as fibrotic, fibrofatty, dense calcium,
and necrotic core. The frequency ofDoppler-detectedmicroembolic signals (MES) duringCAS and the incidence and location
of acute postprocedural embolic lesions detected with DW-MRI were assessed to determine cerebral embolization.
Univariate and correlation analyses were used to assess the association between plaque composition and frequency of
cerebral embolization.
Results: No periprocedural transient ischemic attacks, strokes, or deaths occurred within 30 days. Seventeen patients
(71%) demonstrated new acute cerebral emboli in DW-MRI. Of these, all revealed ipsilateral lesions and 12 (50%) had
contralateral lesions. For the entire study group, the median number of ipsilateral DW-MRI lesions was 1 (range, 0 to 3),
and TCD MES counts were 227 (interquartile range, 143-315). Volumetric VH-IVUS analysis revealed that there was
a trend for larger median dense calcium volume in patients with ipsilateral subclinical cerebral embolism detected with
DW-MRI (33.2  24.5 mm3 vs 11.4  6.1 mm3; P  .08). Scatter plots of plaque components revealed statistically
significant correlation between fibrofatty plaque volume (Spearman r  0.49; P  .016) and number of new ipsilateral
lesions in DW-MRI. Degree of cerebral embolization during CAS measured with TCD correlated with plaque burden,
necrotic core, fibrofatty, and fibrous volumes.
Conclusions: Plaque composition, as determined by VH-IVUS, only weakly correlates with the degree of cerebral
embolization after carotid stenting. Specifically, there is a trend for larger dense calcium volume in patients with distal
embolization. Of note, the proportion of necrotic core, which has traditionally been considered the main component of
a vulnerable or unstable plaque, is not definitely associated with subclinical cerebral embolization after CAS when a filter
device for embolic protection is used. The role of VH-IVUS in evaluating plaque composition during CAS remains
unestablished and warrants further investigation. (J Vasc Surg 2010;52:1188-95.)Carotid artery stenting (CAS) with cerebral protection
is an established treatment option for carotid stenosis in
select patients, particularly those with significant comor-
bidities or a hostile neck from previous surgical procedures
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1188or radiation.1-4 Embolization of plaque debris to the brain
and subsequent stroke continue to be the main complica-
tion of CAS despite the development and widespread use of
embolic protection devices (EPDs).5,6
Carotid plaque composition is currently investigated as
a means of treatment stratification for patients with carotid
artery stenosis.7 Symptomatic clinical presentation has, in
fact, been related to plaques with a large lipid and necrotic
core size, which may result in increased risk of distal embo-
lization during carotid interventions.7-9 Virtual histology
intravascular ultrasound (VH-IVUS) imaging obtained
with an IVUS catheter that is advanced through the lesion
has proved useful to determine plaque composition in the
coronary and carotid arteries.9-12 In theory, determination
of plaque morphology and composition could predict the
embolic potential of carotid lesions that might result in
major adverse events. The role of VH-IVUS during carotid
interventions and whether the use of routine EPDs during
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nerable plaques remain to be established.
The purpose of this study was to assess the relationship
between atherosclerotic plaque composition determined
with VH-IVUS and the occurrence of cerebral emboliza-
tion after carotid stenting. Specifically, the amount of lipid
and necrotic core was assessed as a risk factor for distal
embolization.
METHODS
During a 10-month period, 24 male patients at high
risk or with contraindications for CEA underwent evalua-
tion of target lesions with VH-IVUS at the time of CAS,
transcranial Doppler (TCD) monitoring during CAS, and
pre- and 24-hour postprocedural diffusion-weighted mag-
netic resonance imaging (DW-MRI) scans of the brain.
Indications for CAS included moderate (50% or greater),
symptomatic carotid stenosis, or severe (80% or greater)
asymptomatic carotid stenosis determined with duplex ul-
trasound. Angiographic projections that demonstrated the
most severe degree of stenosis were obtained to confirm the
degree of stenosis. Measurements of angiographic carotid
stenosis (percentage by diameter) were performed accord-
ing to North American Symptomatic Carotid Endarterec-
tomy (NASCET) methodology.13 Neurologic evaluation
was performed using the National Institutes of Health
Stroke Scale (NIHSS) by trained and certified personnel
prior to the procedure, before discharge, and at the 30-day
follow-up visit. Demographic and periprocedural data were
entered into a database designed for this study, which was
approved by the local institutional review board.
All CAS procedures were performed under local anes-
thesia and intravenous sedation through retrograde access
from the common femoral artery. All patients received
dual-antiplatelet therapy with aspirin and a thienopyridine
prior to the procedure and postoperatively. CAS proce-
dures were performed using a fixed angiographic unit (Al-
lura Xper FD20; Philips, Bothell, Wash). Procedural details
and CAS protocols at our institution followed techniques
described in detail before.1 Unfractionated heparin intra-
venous (IV) bolus (100U/kg) was given to achieve a target
activated clotting time (ACT) of 250 to 300 seconds.
Additional heparin was administered approximately every
30 minutes to maintain the ACT within this range. All
procedures were performed with a single filter device for
embolic protection (Accunet filter, Abbott Vascular, Santa
Clara, Calif). Predilatation was selectively performed using
rapid-exchange balloons, 4 mm in diameter and 20 to 40
mm in length. Two self-expanding stents were used: Ab-
bott Acculink and Xact carotid stents (Abbott Vascular).
Postdilatation was also selectively performed using mono-
rail 5- or 5.5-mm balloons if residual stenosis after stent
placement was greater than 20% to 30%. Completion an-
giograms including cervical and cerebral views were rou-
tinely obtained.
Prior to intervention and after EPD deployment, VH-
IVUS images were obtained using a 2.9-F, 20-MHz Eagle
Eye Gold catheter (Volcano Corp, Rancho Cordova, Calif)with an incorporated 20-MHz phased-array transducer be-
ginning from the distal vessel, at least 10 mm distal to the
culprit lesion and progressing in a retrograde direction to
the most distal common carotid artery free of disease.
Manual catheter pullback was used in the initial 15 proce-
dures, whereas motorized pullback at a rate of 1.0 mm/
seconds was used in the last nine cases. The data were stored
on digital video discs and analyzed offline. The image
frames were analyzed by an experienced observer blinded to
the corresponding TCD and DW-MRI imaging studies.
Vessel and lumen area were calculated for each frame, using
previously published methods.14 Plaque burden was calcu-
lated as ([external elastic membranearea  lumenarea/exter-
nal elastic membranearea] 100). Virtual histology analysis
was performed for each frame, and the area of each plaque
constituent (fibrous, fibrofatty, calcific, and necrotic core)
was determined in an automated fashion using Volcano S5
software (Volcano Corp). Planar VH-IVUS analysis was
performed at the site of the minimal luminal area and the
site of the largest necrotic core. Volumetric VH-IVUS
analysis was performed in those cases in which a motorized
pullback was used along the length of the lesion using
Simpson’s rule.14 VH-IVUS analyses are reported in abso-
lute amounts and as percentages (relative amounts) of
plaque area and volume.
All patients had DW-MRI scans of the brain obtained
immediately prior to CAS and 18 to 24 hours after CAS.
DW-MRI was obtained using standard head coils on 1.5
Tesla Siemens scanners (Siemens Avanto or Magnetom
Sonata; Siemens, Erlangen, Germany). DW-MRI with
echo-planar imaging sequence (B0  1000) and fluid-
attenuated inversion recovery (FLAIR) images were ob-
tained in axial and coronal sections. The DW-MRI studies
were then evaluated by neuroradiologists blinded to the
clinical status and the VH-IVUS and TCD data of the
patients. New postprocedural cerebral lesions consistent
with microemboli were recorded in terms of location and
number for all DW-MRI exams performed.
Bilateral transcranial Doppler monitoring of the ante-
rior and middle cerebral arteries was performed using a
PMD150-ST3 digital transcranial Doppler pulsed-wave ul-
trasound system (Spencer Technologies, Seattle, Wash)
with 2-MHz probes located over the temporal bones above
the zygomatic arch. The probes were secured to the pa-
tient’s head using a commercially available probe-holding
head frame system (Marc 600 series; Spencer Technolo-
gies). Doppler parameters were as follows: pulse repetition
frequency, 8 kHz; fast Fourier transformation, 128 points;
overlap, 66%; sample volume axial length, 9 mm; output
power, 80% to 100%; filter, 125 to 175 Hz; noise, 0 to 3
dB; range, 30 dB; Doppler volume, 4 dB; M-mode range,
30 dB; and sweep period, 4 to 16 seconds. Monitoring was
started at the time of femoral puncture and continued for at
least 10 minutes after removal of the embolic protection
device. Timing of all the steps of the stenting procedure,
including advancement of the guides and catheters into the
aortic arch and internal carotid artery, crossing the carotid
lesion with the different devices, deployment of embolic
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ination, filter retrieval, and all the injections of contrast
were recorded in case report forms. The studies were stored
on a hard drive and were analyzed off-line without the use
of the automatic emboli detection software by an investi-
gator who was blinded to patient MRI data. Isolated mi-
croembolic signals (MES) were identified from Doppler
spectrae according to the criteria given by the Consensus
Committee of the Ninth International Cerebral Hemody-
namic Symposium.15 If the number of microembolic sig-
nals was too high to be counted separately, heartbeats with
microemboli were counted as microembolic showers. To
avoid confusion, microembolic signals detected during
contrast injection were excluded from the analysis. For
analysis purposes, the procedure was divided into the fol-
lowing phases: (1) lesion crossing, (2) filter deployment,
(3) IVUS examination, (4) predilation, (5) stent deploy-
ment, (6) postdilation (when applicable), and (7) filter
removal.
Descriptive statistics for categorical variables are pre-
sented as relative frequencies and compared using 2 con-
tingency table analysis or Fisher’s exact test. Continuous
variables were expressed as medians and interquartile
ranges (IQR) or means  standard deviation (SD), if
normally distributed, and compared with Mann-Whitney
U test or Student’s t test for independent samples where
appropriate. The association between plaque components
and the frequency of TCD-detected MES counts during
CAS and the incidence and location of acute postprocedural
embolic lesions detected with DW-MRI were assessed with
bivariate statistical tests, scatter plots, and Pearson or Spear-
man rank correlation coefficients, as appropriate. Statistical
significance was defined by a P value  .05. The SAS 9.2
(SAS Institute, Cary, NC) and MedCalc 11.1.1.0 (MedCalc
Software,Mariakerke, Belgium) software programs were used
for data analyses.
RESULTS
Ten patients (42%) were treated for symptomatic ca-
rotid artery stenosis, and 14 patients (58%) were asymp-
tomatic. The median age was 65 years (IQR, 58-73 years).
Indications for CAS included high surgical risk due to
severe comorbidities (41%), hostile neck (previous CEA,
radical neck dissection, radiation, permanent tracheostomy;
28%), high or low primary or concomitant lesion (lesion
above C2 or below the clavicle; 17%), and contralateral
carotid occlusion (14%). No patients in this series had
tandem lesions. Successful revascularization (30% resid-
ual stenosis) was achieved in all cases. Acculink stents were
used in 11 (46%) procedures and Xact stents in 13 (54%).
No periprocedural transient ischemic attacks, strokes, or
deaths occurred within 30 days.
VH-IVUS was performed without difficulties in all
patients. For the entire group, VH-IVUS revealed a plaque
area of 25.8 mm2 (IQR, 21.8-31) at the minimum luminal
area site and 21.6 mm2 (IQR, 17.4-25) at the largest
necrotic core site. Plaque volume was 342.5 mm3 (IQR,
187-488) for the entire lesion length. Of note, only ninepatients underwent motorized pullback, leading to only
nine values for volumetric assessment. Seventeen patients
(71%) demonstrated new acute cerebral emboli in DW-
MRI. Of these, all revealed ipsilateral lesions and 12 (50%)
also had contralateral lesions. None of the plaque compo-
nents as assessed in planar VH-IVUS analysis at the site of
minimal luminal area and largest necrotic core site was
significantly associated with the presence of ipsilateral cere-
bral embolization as determined by DW-MRI (Table I).
Volumetric VH-IVUS analysis revealed that there was a
trend for larger median dense calcium volume in patients
with new ipsilateral cerebral microemboli compared with
patients without acute lesions as detected with DW-MRI
(33.2 24.5 mm3 vs 11.4 6.1 mm3; P .08; Table II).
The mean proportion of dense calcium volume was, in fact,
larger in patients with cerebral microemboli (9.9 5.2% vs
5.5 0.8%; P.09). Plaque volume (410.9 239.3 mm3
Table I. Virtual histology intravascular ultrasound
findings prior to carotid artery stenting in patients with
and without subclinical cerebral embolization as detected
by diffusion-weighted magnetic resonance imaging
With cerebral
embolizaton
(n  17)
Without cerebral
embolization
(n  7)
P
valuea
Plaque composition at minimum luminal area site (mm2)
Plaque burden 27.5  7.5 26.7  5.1 .81
Fibrous 16.5  7.5 17.4  5.9 .78
Fibrofatty 6.6  4.6 4.2  2.3 .22
Dense calcium 1.0  0.7 1.0  1.4 .88
Necrotic core 3.5  2.7 4.2  2.7 .22
Plaque composition at largest necrotic core site (mm2)
Plaque burden 22.5  7.9 22.1  5.2 .91
Fibrous 13.3  6.4 15.2  4.1 .48
Fibrofatty 4.1  1.1 1.6  0.8 .16
Dense calcium 1.5  1.2 1.2  1.4 .49
Necrotic core 5.2  2.8 6.7  2.2 .22
Data are expressed as mean  standard deviation.
aStudent’s t test for independent samples.
Table II. Plaque volumes determined with virtual
histology intravascular ultrasound prior to carotid artery
stenting in patients with and without subclinical cerebral
embolization as detected by diffusion-weighted magnetic
resonance imaging
With cerebral
embolization
(n  6)
Without cerebral
embolization
(n  3)
P
valuea
Plaque composition over entire lesion length (mm3)
Plaque burden 410.9  239.3 238.9  91.4 .28
Fibrous 172.5  107.2 118.3  48.1 .44
Fibrofatty 61.4  48.2 27.7  14.1 .29
Dense calcium 33.2  24.5 11.4  6.1 .08
Necrotic core 71.9  38.1 40.3  14.4 .22
Data are expressed as mean  standard deviation.
aStudent’s t test for independent samples.vs 238.9  91.4 mm3; P  .28) and necrotic core volume
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larger in patients with ipsilateral acute microemboli, but
these differences did not reach statistical significance. Ipsi-
lateral acute microemboli in DW-MRI did not correlate
with either the volume or proportion of fibrotic and fibro-
fatty plaque components (Tables I and II).
For the entire study group, the median number of
ipsilateral cerebral microemboli was 1 (IQR, 0-3), and the
median total number of DW-MRI acute lesions was 2
(IQR, 0.25-4). Scatter plots of plaque components and
cerebral microemboli as detected with DW-MRI revealed
statistically significant correlation between fibrofatty plaque
volume (Spearman r 0.49; P.016) and number of new
ipsilateral lesions (Fig 1). There was also statistically signif-
icant correlation between the areas of fibrofatty plaque
at the minimum lumen site (Pearson r 0.6; P.002) and
the largest necrotic core site (Pearson r 0.7; P.04) and
the number of microemboli. No significant correlation was
demonstrated between necrotic core and dense calcium
areas and volumes and the number of microemboli.
The median ipsilateral TCD MES counts were 227
(IQR, 143-315). There was statistically significant correla-
tion between the volumes of plaque burden (Spearman r
0.71; P.03), necrotic core (Spearman r 0.71; P.03),
fibrofatty (Spearman r  0.73; P .025), and fibrous
(Spearman r 0.68; P.04) plaque components andMES
counts (Fig 2). No correlation was found between the areas
of plaque components at the minimum lumen and largest
core sites and MES counts.
DISCUSSION
The results of this preliminary study indicate that
plaque composition, as determined by VH-IVUS, slightly
correlates with the degree of cerebral embolization after
carotid stenting. Specifically, there is a trend for an associ-
ation between the volume and proportion of dense calcium
with the occurrence of cerebral embolization after CAS.
Fig 1. Scatter plot of fibrofatty plaque volume and number of
new cerebral microemboli as detected with diffusion-weighted
magnetic resonance imaging (DW-MRI) revealed statistically sig-
nificant correlation (Spearman r  0.49; P .016; dashed lines
indicate 95% confidence limits; solid line, line of equality).The area and volume of fibrofatty plaque do correlate withthe number of ipsilateral cerebral microemboli after CAS as
detected in DW-MRI, whereas volumes of plaque, necrotic
core, fibrofatty, and fibrous components correlate with the
TCD MES counts that occur during CAS. Of note, ne-
crotic core size, which has traditionally been considered the
main component of a vulnerable or unstable plaque, is not
definitely associated with subclinical cerebral embolization
after CAS when a filter device for embolic protection is
used.
Since CAS was introduced for the treatment of carotid
stenosis, cerebral embolization has been considered one of
the main limitations of this procedure. The recognition of
embolization of plaque debris to the brain as the most
significant complication of CAS has prompted intense in-
vestigation on the development of EPDs.5 Despite the
routine use of these devices, particularly of the filter type,
subclinical cerebral embolization during and after CAS almost
universally occurs. TCD monitoring, in fact, reveals that ath-
erosclerotic fragments released from carotid plaques reach
the brain during virtually all CAS procedures.16 Several
neurologic events, however, occur after the procedure,
when the EPD has already been removed, thereby indicat-
ing that a high proportion of stented carotid lesions con-
tinue to release embolic material after the carotid interven-
tion.4 Because strokes after CAS are rare events, particularly
in high-volume-centers and when performed by interven-
tionalists with extensive experience that have already over-
come their learning curve, it may be preferable to use
surrogate end points to characterize cerebral embolization.
Both TCD and DW-MRI have been extensively used and
assessed as effective imaging studies to detect procedural
and postprocedural subclinical cerebral embolization dur-
ing carotid interventions, respectively.16-19 The clinical
significance of these microembolic events is, however, yet
to be defined. In this study, both TCD and DW-MRI were
used to obtain a thorough investigation of the degree of
subclinical cerebral embolization during and after CAS.
Carotid plaque composition is currently investigated as
a means of treatment stratification for patients with carotid
artery stenosis and to define if carotid endarterectomy,
carotid stenting, or medical treatments are indicated.
Symptomatic clinical presentation has, in fact, been related
to plaques with extensive lipid and necrotic core, which
could potentially result in increased risk of distal emboliza-
tion during carotid interventions.7-9 Conversely, fibrous
plaques with low lipid content appear to be more prone to
develop restenosis after intervention.20 A clinical need,
therefore, exists to develop methods to identify these
plaques. VH-IVUS uses spectral analysis of radiofrequency
ultrasound backscatter signals from the IVUS images to
define the four specific plaque components (ie, fibrous,
fibrofatty, dense calcific, and necrotic core areas and vol-
umes within the plaque).10 To our knowledge, the corre-
lation between VH-IVUS and histological examination of
carotid plaques removed during CEA with respect to
plaque compositions has only been assessed in one study.9
A strong correlation between VH-IVUS plaque composi-
tion and histology examination of the same plaques was
ES c
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plaque composition of the coronary arteries using VH-
IVUS has been reported.10-12 Although some studies have
histologically validated VH-IVUS findings for coronary
lesions, plaque characterization using VH-IVUS do not
consistently correlate with histology as to the accurate
identification of plaque components, thereby raising con-
cerns about the accuracy and utility of this imaging tech-
nique.10,21,22 Moreover, the role of VH-IVUS to discern
when embolic protection is indicated during percutaneous
coronary interventions (PCIs) has particularly been ques-
tioned because VH-IVUS is not reliable for the detection of
intravascular thrombus, which is the single most important
predictor for distal embolization during PCIs.23
Two recent studies report on the relationship between
plaque composition determined with VH-IVUS and the
frequency of distal embolization after PCIs in patients with
ST-segment elevation myocardial infarction24 or angina.25
In both studies, the necrotic core size in the culprit lesion
was the major direct correlate and independent predictor of
distal embolization. PCI without embolic protection was
performed in both studies. Contrary to these reports, the
results of our study did not reveal a significant association
between necrotic core size and distal embolization during
CAS. Possible explanations, besides the different anatomic
Fig 2. Scatter plots of plaque components and transc
revealed a statistically significant correlation between the
(B) necrotic core (Spearman r  0.71; P .03), (C)
(Spearman r  0.68; P .04) plaque components and Mlocation and possible type II statistical error due to samplesize, include the routine use of embolic protection in our
study and the presence of disrupted plaques in the coronary
studies. All CAS procedures in our study were performed
with a filter device for embolic protection. Of note, a single
filter device (Accunet filter) was used to avoid variability in
the degree of embolization related to pore size of different
filters. Whether the use of embolic protection effectively pre-
vents distal embolization in plaques with large necrotic cores,
as may be suggested by our findings, remains to be estab-
lished. Unfortunately, no quantification of the amount of
debris recovered in the filters was performed. Although
42% of the patients in our study were symptomatic, none
presented with acute symptoms, which represents a signif-
icant difference with the types of lesions treated in the series
reported by Kawaguchi et al,24 which required mechanical
thrombectomy before VH-IVUS examination could be
performed.
Conventional grayscale and color-flow IVUS has been
used as an adjunct imaging modality during CAS.26 IVUS
provides accurate vessel measurements and may assist in
assessing stent sizing and expansion. To date, however, the
use of VH-IVUS to determine plaque composition and the
potential risk of cerebral embolization during CAS has not
been systematically evaluated. This study, to our knowl-
edge, is the first to assess plaque composition using VH-
l Doppler (TCD) microembolic signal (MES) counts
es of (A) plaque burden (Spearman r 0.71; P.03),
atty (Spearman r  0.73; P .025), and (D) fibrous
ounts.rania
volum
fibrofIVUS and its association with subclinical cerebral emboli-
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demonstrate that carotid plaques with a large necrotic core
size are definitely associated with a higher incidence of
subclinical cerebral embolization. Moreover, necrotic core
areas and volumes failed to correlate with the number of
cerebral microemboli detected on postprocedural DW-
MRI. Our data, therefore, do not support the use of
covered stents or endografts, as suggested in some stud-
ies,9,24 or the avoidance of CAS with embolic protection
with filters for carotid lesions with large necrotic core size
detected in VH-IVUS.
Carotid plaque calcification has been considered an
ominous risk factor for CAS.1 Although difficult to mea-
sure, it is considered that circumferential calcification may
result in inadequate stent expansion and distal emboliza-
tion. The data in this series support the association between
the presence of large dense calcium volume and distal
embolization during CAS. Of interest, large fibrofatty areas
and volume are associated with the number of ipsilateral
microemboli detected in DW-MRI after CAS performed
under embolic protection. One may speculate that more
firm plaque fragments, such as the ones that may originate
in plaques with large fibrofatty and dense calcium compo-
nents, may result in microemboli that may pass through the
pores of a filter. Conversely, fragments that consist of
necrotic core may be effectively caught by the filter.
Whether filters of different pore size and other types of
embolic protectionmay bemore or less effective in prevent-
ing distal embolization remains to be established.
Volumetric analyses revealed that carotid plaque bur-
den and the extent of necrotic core, fibrofatty, and fibrous
components correlate with TCDMES counts during CAS.
Of note, only nine patients underwent motorized pullback,
leading to only nine values for volumetric assessment. Al-
though higher MES counts may be associated with in-
creased risk of ischemic stroke in several medical condi-
tions, such association in patients undergoing CAS has not
been established, and the significance of MES counts seen
during CAS remains to be elucidated. Because fibrofatty
plaque volume correlates with the number of ipsilateral
microemboli detected in DW-MRI and the MES counts,
this component better predicts the frequency of subclinical
cerebral embolization during and after CAS.
Although this study includes prospectively collected
data of VH-IVUS of target carotid lesions, TCD monitor-
ing during CAS, and DW-MRI exams obtained before and
after CAS, important limitations should be acknowledged.
First of all, our study includes a small sample size, and the
findings were not validated in an independent control
group of patients; thus, the observations should be consid-
ered preliminary. Second, the patterns observed on VH-
IVUS may not consistently correlate with histology, which
could not be assessed in this study, as the filter contents
were not quantitatively and qualitatively assessed. Third, all
patients in our study underwent CAS under embolic pro-
tection, which could have limited the utility of VH-IVUS
to determine the risk of distal embolization during CAS.
Because CAS without embolic protection is rarely per-formed due to ethical and regulatory considerations, our
findings do apply to current clinical practice. Fourth, our
results indicate that carotid plaque composition can only
weakly predict distal embolization, and even if we could
accurately predict lesions most likely to embolize, it is
unclear if distal subclinical embolization may be prevented
and, if so, does that translate into better clinical outcomes?
Fifth, becausemotorized pullback of the IVUS catheter was
only performed in 9 of 24 patients, volumetric analysis of
plaque composition was only feasible in 38% of the carotid
lesions. Our results indicate that volumes rather than areas
of plaque components are more relevant to predict risk of
embolization, which may require a larger sample size to
confirm our findings. Finally, further characterization of
vulnerable carotid plaques using VH-IVUS, including the
presence of thin-cap fibroatheroma and plaque rupture, was
not assessed in this study. Notwithstanding these limita-
tions, our study provides potentially interesting informa-
tion that needs to be validated prospectively in larger
cohorts of patients. The clinical significance of subclinical
cerebral embolization after CAS, the effectiveness of distal
protection devices in preventing embolization, and the
ultimate impact of reducing distal embolization on the
frequency of stroke remain uncertain and warrant further
investigation.
CONCLUSIONS
Carotid plaque composition, as determined by VH-
IVUS, only weakly correlates with the degree of subclinical
cerebral embolization after carotid stenting. Specifically,
there is a trend for an increased incidence of cerebral
embolization after CAS in patients with a higher volume
and proportion of dense calcium and a significant correla-
tion between fibrofatty volume and the number of new
lesions detected in DW-MRI. Conversely, and despite be-
ing considered the main component of unstable or vulner-
able plaques, necrotic core size is not definitely associated
with subclinical cerebral embolization after CAS under
embolic protection. According to our results, the role of
VH-IVUS in evaluating plaque composition during CAS
remains to be established and warrants further investiga-
tion.
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Peter H. Lin (Houston, Tex). Dr. Timaran and colleagues
from the University of Texas Southwestern Medical Center pre-
sented an excellent study in which they analyzed the predictive
factors of plaque embolization during carotid stenting using vari-
ous imaging modalities, which included virtual histology IVUS,
transcranial Doppler, and diffusion-weighted MRI. The authors
reported a weak correlation regarding the risk of plaque emboliza-
tion as assessed by virtual histology IVUS during carotid artery
stenting. However, patients with high calcium plaque volume are
associated with an increased risk of subclinical cerebral emboliza-
tion.
I have three questions for the authors:
The risk of carotid plaque embolization during carotid
artery stenting has been a subject of intense investigation over
the past decade. There are emerging data to show that hypo-
echoic plaque as assessed by grayscale median analysis using
conventional carotid duplex scan is associated with an increasedment can also be analyzed by intravascular ultrasound. Can you
share with us your thoughts regarding the role of plaque
echomorphology using grayscale median analysis as determined
by either IVUS or carotid duplex ultrasound with regards to the
risk of plaque embolization?
Regarding my second question, there are emerging reports
from the European colleagues suggesting a protective role of statin
therapy, which may stabilize carotid plaques and reduce the possi-
bility of plaque progression as well as plaque embolization during
carotid interventions. Conversely, patients with poorly controlled
hyperlipidemia have been shown to have a higher risk of stroke
following carotid interventions, presumably due to a high risk of
plaque embolization. Did you examine the lipid profile of your
patients, and can you share your thoughts on the role of statin
therapy regarding the risk of carotid plaque embolization?
Lastly, what clinical practice implications can you provide,
based on the findings of your study, so that carotid stenting
procedures can be performed in a safer manner? Should we con-
JOURNAL OF VASCULAR SURGERY
Volume 52, Number 5 Timaran et al 1195sider a neuroprotective filter device with smaller porosity when
encountering high calcium volume plaque density? Or should we
use a flow-reversal neuroprotective device when encountering
plaque with high calcium or fibrofatty volume?
I enjoyed this presentation and would also like to congratulate
the authors for a well-designed and well-presented study. I would
also like to thank the authors for providing me with a well-written
manuscript in a timely fashion. Lastly, I would like to thank the
Association for the opportunity to discuss this study.
Carlos Timaran. Thank you, Peter, for your comments and
questions. I do believe that assessing plaque composition is impor-
tant prior to any carotid intervention. Not to mention, the gray
scale median (GSM) is one of the most important methods and its
importance is that it is derived from a noninvasive imaging modal-
ity (ie, duplex ultrasound). There are some studies that have shown
that low GSM is associated with increased risk of embolization
after carotid stenting. We are prospectively collecting duplex ultra-
sound images to correlate the degree of embolization with our VH
IVUS findings and GSM. Unfortunately, I don’t have those data
with me today, but I think those are important and may allow us to
identify patients at high risk of embolization prior to carotid
stenting. Regarding the use of statins, more than 90% of ourpatients were on statins, so what you are seeing here is carotid
plaques that were developed in the presence of a statin. There are
studies that actually show that statins can modify the plaque
composition; specifically, they may decrease the amount of lipids in
the carotid plaque. I do believe that this finding has implications,
particularly for those patients that will be managed with best
medical therapy. Regarding the effectiveness of embolic protec-
tion, what we are seeing here is the effects of plaque composition in
patients that are undergoing a procedure under embolic protection
with a filter. Our idea was to see how effective the filters were in
those patients, particularly those with large necrotic core. Regard-
ing recommendations about our findings, I do believe that we need
to explore further the use of this imaging modality (ie, virtual
histology IVUS). There is some information and findings that we
have presented here; one of them is that if you have substantial
dense calcium, you have to be careful about proceeding with
stenting as there was a trend, although not statistically significant,
to increased embolization in these cases. Obviously, different
embolic protection devices may offer different results in terms of
plaque composition, so that needs to be addressed in future
studies, too.
